Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics Thermo Fisher Scientific Inc. the world leader in serving science, announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the…
Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows Revvity, Inc. announced that its Revvity Signals Software business is launching Signals BioDesignTM, a cloud-native molecular cloning solution that streamlines biologics research workflows. Built for biotech and pharma R&D teams,…
Gulf Coast Midstream Partners Secures Investment from Black Bay Partners to Advance the Development of Natural Gas Storage Hub in Southeast Texas Gulf Coast Midstream Partners, LLC a private developer of energy midstream assets, today announced a growth capital investment…
Cloud Range Wins Gold in 2026 Cybersecurity Excellence Awards for Cyber Readiness and Validation Cloud Range, the industry-leading cyber readiness and simulation platform, has been named a Gold Award recipient in the Cyber Readiness and Validation category of the 2026…
CatalYm Doses First Patient in Phase 2b Trial Evaluating Visugromab in Combination with Chemoimmunotherapy as Second-Line Treatment in Unresectable/Metastatic Hepatocellular Carcinoma CatalYm announced that the first patient has been dosed in the GDFATHER-HCC-01 trial The trial evaluates the company’s lead anti-GDF-15…
Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Pulse Biosciences, Inc. developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced enrollment of the first…
AIRNA Announces First Patient Dosed in Phase 1 Trial of AIR-001, Potential Best-in-Class RNA-Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD) AIRNA, a biotech company pioneering RNA-editing therapeutics to transform the lives of patients with rare and common conditions, announced the…
Ducon Announces Advanced Solutions to Mitigate Air Pollution from Missile Interceptions Ducon Technologies a global leader in high-efficiency air pollution control and infrastructure related technologies, announced solutions for the escalating environmental and public health crisis caused by high-altitude missile interceptions…
Aspect Biosystems Announces $280 Million Partnership with Government of Canada to Advance Development of Bioengineered Cellular Medicines Aspect Biosystems, a biotechnology company pioneering a novel category of regenerative medicine, today announced that it has received a $79 million investment from…
Swaney Group Capital and LongueVue Capital Invest in Apex Dental Laboratory Group Swaney Group Capital a Tampa-based private equity firm, in partnership with LongueVue Capital a New Orleans-based private equity firm, announced a strategic investment in Apex Dental Laboratory Group (“Apex”…
CTIS, Inc. Launches Trial SafetyXchange to Help Pharma Companies Meet Critical FDA E2B(R3) Compliance Deadline CTIS, Inc., with more than 30 years of experience in Health IT and clinical research informatics expertise for government and industry clients, today announced the…
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board Harmony Biosciences Holdings, Inc. announced the appointment of Peter Anastasiou as Chief Operating Officer and updates to its Board of Directors, including the appointment of Troy…